ImmunoCellular Therapeutics (IMUC) Prices Offering of Convertible Preferred Stock and Warrants Jul 18, 2017 06:27AM
ImmunoCellular Therapeutics Announces Pricing of Public Offering of Convertible Preferred Stock and Warrants Jul 18, 2017 06:00AM
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update Mar 9, 2017 04:05PM
Maxim Group Downgrades ImmunoCellular Therapeutics (IMUC) to Hold Nov 11, 2016 07:59AM
ImmunoCellular Therapeutics Announces Third Quarter 2016 Financial Results and Provides Research and Development Update Nov 10, 2016 04:05PM


Aug 22, 2016 04:10PM ImmunoCellular Therapeutics (IMUC) Tops Q2 EPS by 1c
Aug 22, 2016 04:05PM ImmunoCellular Therapeutics Announces Second Quarter 2016 Financial Results
Aug 9, 2016 08:46AM ImmunoCellular Therapeutics (IMUC) Prices 47M Share Stock Offering for Proceeds of $7.4M
Aug 9, 2016 08:45AM ImmunoCellular Therapeutics Announces Pricing of $7.4 Million Public Offering
Dec 4, 2015 09:00AM Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report
Dec 1, 2015 09:52AM ImmunoCellular (IMUC) Bullish View Reiterated at Maxim Group Amid ICT-107 Agreement
Nov 19, 2014 07:20AM Maxim Group Maintains Bullish Stance on ImmunoCellular (IMUC) Following Review of SNO Data and Plans for Phase III
Sep 24, 2014 09:32AM Pre-Open Stock Movers 9/24: (LPCN) (MACK) (ACOR) Higher; (ECTE) (ATOS) (GTI) Lower (more...)
Dec 16, 2013 10:27AM Maxim Group Sees More than 500% Upside in Agenus (AGEN) Amid Results
Sep 6, 2012 01:01PM Unusual 11 Mid-Day Movers 09/06: (RDN) (NAV) (MW) Higher; (OCZ) (FCEL) (PAY) Lower
Sep 6, 2012 10:35AM Notable Analyst Rating Changes 09/06: (AKS) (ATVI) (GOLD) Upgraded; (NOK) (CLF) (OCZ) Downgraded
Sep 6, 2012 09:47AM ImmunoCellular Therapeutics (IMUC) Ramps on New Buy Rating